SCHEMBL20109644

SCHEMBL20109644

Cc1ccc(N(c2ccc3c(c2)sc2ccccc23)c2ccc3c(c2)sc2ccccc23)cc1N(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.41
▸ MAPT P10636 7/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ HPGD P15428 2/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ GPR3 P46089 1/20 0.39
▸ L3MBTL1 Q9Y468 5/20 0.33
▸ POLB P06746 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ GABRP O00591 1/20 0.32
▸ GABRD O14764 1/20 0.32
▸ GABRA1 P14867 1/20 0.32
▸ GABRB1 P18505 1/20 0.32
▸ GABRG2 P18507 1/20 0.32
▸ GABRB3 P28472 1/20 0.32
▸ GABRA5 P31644 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109643 0.92 GPR3 (0.39) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL14295427 0.87 GPR3 (0.52) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL29854450 0.87 GPR3 (0.52) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL21966474 0.87 GPR3 (0.52) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL25492349 0.87 GPR3 (0.52) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL19801859 0.86 GPR3 (0.34) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL20109609 0.84 ALDH1A1 (0.37) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL19801845 0.84 ALDH1A1 (0.49) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL19801848 0.84 ALDH1A1 (0.49) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL14295418 0.84 ALDH1A1 (0.49) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180123048-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180123048-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF PIEZO1, OCIAD1, LEF1 ALDH1A1 493/4885MAPT 2943/4885RAB9A 3223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback